Lifestyle

Pfizer 2Q profit surges, company sees drug rebates ending

Pfizer’s top executives are predicting the Trump administration will try to eliminate big rebates off prescription drug prices that manufacturers pay to middlemen, a move that could sharply reduce patients’ out-of-pocket costs. Pfizer shares jumped […]